We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




International Genomics Consortium Licenses Sapphire Biobanking Solution

By Labmedica staff writers
Posted on 21 Jul 2008
The International Genomics Consortium (IGC; Phoenix, AZ, USA) has licenced LabVantage Solutions, Inc (Bridgewater, NJ, USA) Sapphire BioBanking Solution. More...
The IGC chose Sapphire because of its product maturity, functionality, architecture, scalability, and flexibility.

A zero-footprint laboratory-information management suite, Sapphire is designed to manage an organization's critical laboratory information across worldwide operations, to optimize productivity, and more effectively share knowledge. The Sapphire BioBanking Solution ensures that standard procedures are used for all steps in the biorepository management process. Key processes supported include: informed consent, clinical data collection, sample collection, pathology review, biomolecule extractions, quality control, laboratory data collection, and biomolecule distribution.

A non-profit foundation, the IGC was established to expand upon the discoveries of the Human Genome Project and other systematic sequencing efforts by combining diagnostic technologies, genomic research, and bioinformatics, in the fight against cancer and other complex genetic diseases. The foundation has a number of functions including: standardization of the collection of properly consented tissues of interest, molecular characterization of these tissues, and standardization in the representation of these results. The IGC facilitates the transition of genomic discoveries to improve patient care and increase the speed in which new diagnostic, prognostic and predictive testing, and new drug and treatment regimens are developed.

The [U.S.] National Cancer Institute (NCI; Bethesda, MD, USA) and the [U.S.] National Human Genome Research Institute (NHGRI; Bethesda, MD) chose the IGC to lead the Human Cancer Biospecimen Core Resource (BCR) component of The Cancer Genome Atlas (TCGA) pilot project. The Sapphire BioBanking Solution will serve as a key informatics backbone supporting and maintaining the BCR.

"In order for the IGC to successfully implement the Human Cancer Biospecimen Core Resource we needed a biospecimen management solution that was functionally rich and capable of being implemented rapidly,” stated Troy Shelton, IGC project administrator for TCGA. "Among the software solutions we evaluated, LabVantage's Sapphire BioBanking Solution offered true out-of–the-box functionality and was by far the most well-established and premier solution used by peers in the industry.”


Related Links:
International Genomics Consortium
LabVantage Solutions
National Cancer Institute

New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Serological Pipet Controller
PIPETBOY GENIUS
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: Pancreas cells (left) showing early stages of malignant cancer in brown and same cells stained blue (right) indicate they are Integrin β3 (ITGB3) positive (Photo courtesy of UC San Diego Health Sciences)

Gene Signature Could Serve as Early Warning System for Aggressive Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal forms of cancer, with early detection remaining a major challenge. Precancerous cells must overcome significant stress and... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Microbiology

view channel
Image: The groundbreaking salmonella antimicrobial resistance prediction platform has demonstrated 95% accuracy (Photo courtesy of Yujie You et al., DOI: 10.1016/j.eng.2025.01.013)

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance

Antimicrobial-resistant Salmonella strains are a growing public health concern due to the overuse of antimicrobials and the rise of genetic mutations. Accurate prediction of resistance is crucial for effective... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.